The pharmaceutical industry confronts a daunting challenge: achieving the optimal balance between rapid drug development and sustainable practices. While the urgency for swift advancements to address global health concerns is undeniable, it's crucial to reduce the industry's carbon emissions. This delicate balance demands a integrated approach that